Programmed Death-ligand 1 Expression Analysis for Non-small Cell Lung Cancer in Tissues Sampled Using Different Methods

Journal Title: The Medical Bulletin of Haseki - Year 2020, Vol 58, Issue 2

Abstract

Aim: This study aims at investigating the concordance of programmed death-ligand 1 (PD-L1) expression in non-small cell cancer tissues that have been sampled using different methods and its relationship with the pathologic parameters of tumors. Methods: PD-L1 expression assays were made on the cell blocks taken using fine needle aspiration, the small tissue samples representing endoscopic biopsy and the large tissue samples representing the resected tumor taken from the tumors of 100 subjects diagnosed with non-small cell lung cancer; their percentage values were evaluated and their groups were determined based on these values. Results: The average difference in expression rates found through different sampling methods was close to 0, and the values of such differences changed mostly in a narrow range. In paired comparisons, a good level of concordance was observed between all the sampling methods. The values were 0.8865 (SE: 0.0306, CI: 0.8264-0.9466) in the comparison of tumor tissue (TT) and small biopsy (SB): 0.8637, (SE: 0.033, CI: 0.7989-0.9285) TT to cell block (CB): 0.8916, (SE: 0.0272, CI: 0.8383-0.9449) SB tissue to the CB. Conclusion: Therefore, it can be concluded that the PD-L1 expression does not differ between the tissues sampled through various methods in non-small cell lung cancers.

Authors and Affiliations

Halide Nur Ürer, Mehmet Zeki Günlüoğlu, Levent Cansever, Mehmet Ali Bedirhan

Keywords

Related Articles

Genetic Variations of miRNAs and the Risk of Oral Squamous Cell Carcinoma: A Case-control Study

Aim: In this study, we investigated the association between two miRNA variants and the risk of oral squamous cell carcinoma (OSCC), and explored the interaction between clinical factors in the Turkish population. Method...

A Novel Frameshift Mutation in Two Siblings with Merosin-deficient Congenital Muscular Dystrophy

We present two siblings with elevated serum creatine kinase concentrations, developmental delay, muscle weakness, and contractures of the lower limbs. Cranial magnetic resonance imaging revealed diffuse white matter hype...

Relationship Between SUVmax and Ki-67 Expression in Breast Cancer

Aim: Breast cancer is the most common type of cancer in women. The Ki-67 antigen is a factor used for subgrouping of luminal breast cancer into A and B subtypes. 18F-fluorodeoxyglucose positron emission tomography/comput...

Comparison of Retrograde Intrarenal Surgery and Micro-percutaneous Nephrolithotomy for Kidney Stones 5-10 mm in Diameter

Aim: To compare the results of micro-percutaneous nephrolithotomy (micro-PNL) and retrograde intrarenal surgery (RIRS) for symptomatic renal stones 5-10 mm in diameter. Methods: A total of 86 patients, who underwent RIR...

The Diagnostic Value of Ischemia-modified Albumin in Prostate Cancer

Aim: The aim of this study was to investigate whether serum ischemia-modified albumin (IMA) levels have a diagnostic value in prostate cancer (Pca). Methods: Thirty primary Pca patients and 30 age-matched healthy male s...

Download PDF file
  • EP ID EP685270
  • DOI 10.4274/haseki.galenos.2020.5681
  • Views 116
  • Downloads 0

How To Cite

Halide Nur Ürer, Mehmet Zeki Günlüoğlu, Levent Cansever, Mehmet Ali Bedirhan (2020). Programmed Death-ligand 1 Expression Analysis for Non-small Cell Lung Cancer in Tissues Sampled Using Different Methods. The Medical Bulletin of Haseki, 58(2), -. https://europub.co.uk/articles/-A-685270